1.TREATMENT OF MAJORLIN`S ULCER: THE ROLE OF COMBINATION CHEMOTHERAPY.
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1997;24(4):761-765
No abstract available.
Drug Therapy, Combination*
;
Ulcer*
2.5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma.
Ki Hyeong LEE ; Won Ki KANG ; Chang In SUH ; Young Suk PARK ; Heung Tae KIM ; Yoon Koo KANG ; Hyo Jin KIM ; Dae Seog HEO ; Yung Jue BANG ; Yong Bum YOON ; Noe Kyeong KIM ; Yong Hyun PARK
Journal of the Korean Cancer Association 1991;23(2):315-322
No abstract available.
Drug Therapy, Combination*
;
Epirubicin*
;
Fluorouracil*
3.Combination chemotherapy for the treatment of multiple myeloma.
Hyo Jin KIM ; Chang In SEO ; Keun Chil PARK ; Heung Tae KIM ; Dae Seog HEO ; Yung Hue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):577-585
No abstract available.
Drug Therapy, Combination*
;
Multiple Myeloma*
4.Modified COP-BLAM combination chemotherapy for the non-Hodgkin's lymphoma.
Journal of the Korean Cancer Association 1991;23(2):331-336
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
5.Gynecologic oncology group trials in uterine corpus malignancies: recent progress.
David Scott MILLER ; Louise P KING
Journal of Gynecologic Oncology 2008;19(4):218-222
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.
Carcinosarcoma
;
Drug Therapy, Combination
;
Endometrial Neoplasms
;
Female
6.Gynecologic oncology group trials in uterine corpus malignancies: recent progress.
David Scott MILLER ; Louise P KING
Journal of Gynecologic Oncology 2008;19(4):218-222
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to malignancies of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.
Carcinosarcoma
;
Drug Therapy, Combination
;
Endometrial Neoplasms
;
Female
7.COP-BLAM III(cyclophosphamide/vincristine/prednisolone/bleomycin/ adriamycin/procarbazine) combination chemotherapy for the treatment of intermediate and high grade non-Hodgkin's lymphoma.
Keong Hae JUNG ; Young Iee PARK ; Kee Heung LEE ; Young Suk PARK ; Chang In SUH ; Won Ki KANG ; Heung Tae KIM ; Cheol Won SUH ; Dae Seog HEO ; Yung Jue BANG ; Seonyang PARK ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(4):586-595
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
8.Etoposide, adriamycin, cisplatin(EAP) combination chemotherapy for advanced gastric cancer.
Joon Sik KIM ; Jeong Hee KIM ; Own Gyu UH ; Si Young KIM ; Hwi Joong YOON ; Kyung Sam CHO
Journal of the Korean Cancer Association 1992;24(4):562-569
No abstract available.
Doxorubicin*
;
Drug Therapy, Combination*
;
Etoposide*
;
Stomach Neoplasms*
9.A randomized comparison of antiemetic effect of ondansetron versus MDL(metoclopramide/dexamethasone/lorazepam) in patients receiving cisplatin-based combination chemotherapy.
Young Hyuck IM ; Young Suk PARK ; Joungsoon JANG ; Jae Yong LEE ; Sungsoo YOON ; Dae Seog HEO ; Yung Jue BANG ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(3):378-389
No abstract available.
Antiemetics*
;
Drug Therapy, Combination*
;
Humans
;
Ondansetron*
10.Treatment of intermediate-grade non-Hodgkin's lymphoma with CAMP-MOB combination chemotherapy.
Chang In SUH ; Heung Tae KIM ; Dong Bok SHIN ; Jae Hoon LEE ; Dae Seog HEO ; Yung Jue BANG ; Seonyang PARK ; Byoung Kook KIM ; Noe Kyeong KIM
Journal of the Korean Cancer Association 1992;24(1):102-108
No abstract available.
Drug Therapy, Combination*
;
Lymphoma, Non-Hodgkin*
Result Analysis
Print
Save
E-mail